CM Delivered PST in LLD Pilot
Examining the Feasibility and Effectiveness of Case Manager Delivered Problem Solving Therapy on Late Life Depression: An Open-label Prospective Pilot Study
1 other identifier
interventional
29
1 country
1
Brief Summary
This study seeks to determine the feasibility and efficacy of a Problem Solving Therapy intervention for the treatment of late life depression (LLD). Participants diagnosed with LLD will participate in 8 weekly sessions of Problem Solving Therapy, a form of talk-therapy, over a period of eight weeks. A Case Manager (CM) trained in this therapy will lead the PST sessions. Participants will attend a clinical assessment pre and post study intervention to assess depression severity, quality of life, anxiety, insomnia, functional disability, and participant's acceptability of the intervention. Additionally self-rated depression will be collected weekly over 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedStudy Start
First participant enrolled
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedJune 11, 2019
June 1, 2019
1.3 years
January 18, 2018
June 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Successful implementation of Problem Solving Therapy (PST).
The primary outcome measure will be if CM delivered PST can be successfully implemented in the London Health Sciences Centre geriatric outreach program. If the recruitment goal of n=40 is met within 1 year, and 60% of participants complete the PST program, missing no more than 3 of the 8 weekly follow-ups, the primary objective will be considered to be met.
10 weeks
Secondary Outcomes (6)
Depression severity as measured by the Hamilton Depression Scale (HAM-D17)
Week 0, week 9.
Quality of life as measured by the EuroQol 5 Dimension 5 level (EQ-5D-5L).
week 0, week 9.
Anxiety severity as measured by the Generalized Anxiety Disorder 7-item (GAD-7) scale.
week 0, week 9.
Insomnia severity as measured by the Athens Insomnia Scale.
week 0, week 9.
Functional disability as measured by the World Health Organization Disability Assessment Schedule 2 (WHODAS-2).
week 0, week 9.
- +1 more secondary outcomes
Study Arms (1)
Problem Solving Therapy
EXPERIMENTALAll participants will attend 8 weekly sessions of Case Manager delivered Problem Solving Therapy.
Interventions
Participants will attend 8 weekly session of Case Manager (CM) implemented PST, a form of group talk therapy.
Eligibility Criteria
You may qualify if:
- Participants will be considered eligible for the study if they:
- Are of either gender and 60 years of age or greater.
- Reside in a community setting (either independent living environment or retirement home).
- Meet diagnostic criteria for major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) criteria.
- Have a Hamilton Depression Rating Scale (HAMD) 17-item total score of \>= 8 and \< 24 at baseline.
- Have a Mini Mental Status Exam score of \>= 25.
- Have adequate hearing and vision to be able to participate in Problem Solving Therapy, with no significant sensory impairment
- Fluent in English both written and oral.
You may not qualify if:
- Participants will be considered ineligible for participating in the study if they:
- Have suicidal ideation requiring inpatient admission to hospital for stabilization.
- Have an unstable medical condition requiring hospital admission.
- Have a life expectancy of less than 6 months or are currently receiving palliative care.
- Have psychotic symptoms.
- Have a lifetime history of bipolar disorder or schizophrenia.
- Are currently alcohol dependent or have another substance dependence.
- Are diagnosed with moderate to severe dementia.
- Are planning admission to a long-term care facility within next 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2018
First Posted
January 24, 2018
Study Start
February 1, 2018
Primary Completion
May 31, 2019
Study Completion
May 31, 2019
Last Updated
June 11, 2019
Record last verified: 2019-06